ORLANDO, Fla., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Innventure, Inc. (NASDAQ: INV) (“Innventure”), a technology commercialization platform, today announced financial results for the quarter ended ...

Connect Hearing is now offering the groundbreaking Audéo Sphere™ hearing aids, the world’s first hearing aids equipped with a ...

Phonak Audéo Sphere™ hearing aids are now available at Connect Hearing clinics and are a part of Phonak’s new Infinio line of ...

BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer ...

NASCAR race coming to historic quarter-mile track in early February and the upgrades will help the weekly racing series and ...

Argentina are back in action on Thursday with a trip to Asuncion to face a tough Paraguay test with a chance to inch closer ...

Robert W. Baird analyst Brian Skorney maintained a Buy rating on Crinetics Pharmaceuticals (CRNX – Research Report) on November 12 and ...

It may be tough to single out any particular ones as the worst of the bunch, but allow me to suggest two contenders: tech ...

Zymo’s Quick DNA/RNA Viral MagBead Kit was automated using Analytik Jena’s Cybio FeliX pipetting robot. The CyBio FeliX ...

Tapestry, the owner of Coach, said it would abandon its $8.5 billion deal to buy Capri, the parent company of Michael Kors, ...

To promote competition and prevent market dominance, Optum and Amedisys have agreed to divest numerous home health and hospice centers to VitalCaring upon the transaction’s completion. VitalCaring ...

In June, GSK released results from an interim analysis of the DREAMM-8 phase 3 head-to-head trial of Blenrep in combination with pomalidomide plus dexamethasone (PomDex), versus a standard of care, ...